- 関
- oral、orally、p.o.、peroral、perorally
WordNet
- of or relating to or affecting or for use in the mouth; "oral hygiene"; "an oral thermometer"; "an oral vaccine"
- an examination conducted by spoken communication (同)oral exam, oral_examination, viva voce, viva
- using speech rather than writing; "an oral tradition"; "an oral agreement" (同)unwritten
- a stage in psychosexual development when the childs interest is concentrated in the mouth; fixation at this stage is said to result in dependence, selfishness, and aggression
- of or involving the mouth or mouth region or the surface on which the mouth is located; "the oral cavity"; "the oral mucous membrane"; "the oral surface of a starfish"
- (of drugs) through the mouth rather than through injection; by_mouth; "he was administered the drug orally"
- by spoken rather than written means; "these stories were transmitted by word of mouth" (同)by_word_of_mouth
- the displacement of any point due to the superposition of wave systems is equal to the sum of the displacements of the individual waves at that point; "the principle of superposition is the basis of the wave theory of light" (同)Huygens'' principle of superposition
- a mouth or mouthlike opening
- the 17th letter of the Hebrew alphabet
PrepTutorEJDIC
- 『口頭の』,口述の(spoken) / 口の,口部の / 経口の
- 口頭で,口述で
- …『につき』,…ごとに / 《文》…によって,…で,…を通じて / 《しばしば『as per』…で》…によって示された通りに,…に従って
- osmiumの化学記号
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/12/08 20:58:09」(JST)
[Wiki en表示]
Oral administration (per os) is a route of administration where a substance is taken through the mouth. Many medications are taken orally because they are intended to have a systemic effect, reaching different parts of the body via the bloodstream, for example.[1]
Contents
- 1 Terminology
- 2 Scope
- 3 Facilitating methods
- 4 Documentation
- 5 See also
- 6 References
Terminology[edit]
Per os (//; P.O.) is an adverbial phrase meaning literally from Latin "by mouth" or "by way of the mouth." The expression is used in medicine to describe a treatment that is taken orally. The abbreviated P.O. is often used on medical prescriptions. P.O. is also occasionally (and grammatically incorrectly; os is a neuter noun of the 3rd declension and thus the accusative is the same as the nominative) rendered per orem, which is sometimes corrupted to per oram.
Scope[edit]
Oral administration is a part of enteral administration, which also includes
- buccal (dissolved inside the cheek)
- sublabial (dissolved under the lip) and
- sublingual administration (dissolved under the tongue).
Enteral medications come in various forms, including:[1]
- tablets to swallow, chew or dissolve in water or under the tongue
- capsules and chewable capsules (with a coating that dissolves in the stomach or bowel to release the medication there)
- time-release or sustained-release tablets and capsules (which release the medication gradually)
- powders or granules
- teas
- drops
- liquid medications or syrups.
Facilitating methods[edit]
Concomitant ingestion of water facilitates in swallowing tablets and capsules.[2] If the substance has disagreeable taste, addition of a flavor may facilitate ingestion.[2] Substances that are harmful to the teeth are preferably given through a straw.[2]
Documentation[edit]
Dating and time-stamping of pharmaceutical ingestion can be automatically documented by concomitantly administrating an ingestible sensor, whose consumption can be detected by an externally worn adhesive monitor.[3]
See also[edit]
- Nil per os
- List of Latin phrases
- Medical prescription
- List of abbreviations used in medical prescriptions
References[edit]
- ^ a b Institute for Quality and Efficiency in Health Care. "Oral medications". Informed Health Online. Institute for Quality and Efficiency in Health Care. Retrieved 22 June 2013.
- ^ a b c TheFreeDictionary > oral administration of medication Citing: Mosby's Medical Dictionary, 8th edition. 2009
- ^ Dicarlo, L. A. (2012). "Role for direct electronic verification of pharmaceutical ingestion in pharmaceutical development". Contemporary Clinical Trials 33 (4): 593–600. doi:10.1016/j.cct.2012.03.008. PMID 22487008. edit
Routes of administration / Dosage forms
|
|
Oral |
Digestive tract (enteral)
|
Solids
|
- Pill
- Tablet
- Capsule
- Time release technology
- Osmotic delivery system (OROS)
|
|
Liquids
|
- Elixir
- Emulsion
- Hydrogel
- Molecular encapsulation
- Softgel
- Solution
- Suspension
- Syrup
- Tincture
- Tisane
|
|
|
Buccal (Sublabial) Sublingual
|
Solids
|
- Orally disintegrating tablet (ODT)
- Film
- Lollipop
- Lozenges
- Chewing gum
|
|
Liquids
|
- Mouthwash
- Toothpaste
- Ointment
- Oral spray
|
|
|
Respiratory
tract
|
Solids
|
- Smoking device
- Dry powder inhaler (DPI)
|
|
Liquids
|
- Anaesthetic vaporizer
- Vaporizer
- Nebulizer
- metered-dose inhaler (MDI)
|
|
Gas
|
- Oxygen mask
- Oxygen concentrator
- Anaesthetic machine
- Relative analgesia machine
|
|
|
|
|
Ophthalmic /
Otologic / Nasal |
- Nasal spray
- Ear drops
- Eye drops
- Ointment
- Hydrogel
- Nanosphere suspension
- Mucoadhesive microdisc (microsphere tablet)
|
|
Urogenital |
- Ointment
- Pessary (vaginal suppository)
- Vaginal ring
- Vaginal douche
- Intrauterine device (IUD)
- Extra-amniotic infusion
- Intravesical infusion
|
|
Rectal (enteral) |
- Ointment
- Suppository
- Enema
- Murphy drip
- Nutrient enema
|
|
Dermal |
- Ointment
- Liniment
- Paste
- Film
- Hydrogel
- Liposomes
- Transfersome vesicles
- Cream
- Lotion
- Lip balm
- Medicated shampoo
- Dermal patch
- Transdermal patch
- Transdermal spray
- Jet injector
|
|
Injection / Infusion
(into tissue/blood) |
Skin
|
- Intradermal
- Subcutaneous
- Transdermal implant
|
|
Organs
|
- Intracavernous
- Intravitreal
- Intra-articular injection
- Transscleral
|
|
Central nervous system
|
- Intracerebral
- Intrathecal
- Epidural
|
|
Circulatory / Musculoskeletal
|
- Intravenous
- Intracardiac
- Intramuscular
- Intraosseous
- Intraperitoneal
- Nanocell injection
|
|
|
Routes of administration by organ system
|
|
Gastrointestinal |
- Oral
- Buccal
- Sublabial
- Sublingual
- Rectal
|
|
Respiratory system |
|
|
Visual system /
Auditory system |
- Ocular (Ocular-topical / Intravitreal / Transscleral)
- Otologic (Oto-topical)
|
|
Reproductive system |
- Intracavernous
- Intravaginal
- Intrauterine (Extra-amniotic)
|
|
Urinary system |
|
|
Peritoneum |
|
|
Central nervous system |
- Intracerebral
- Intrathecal
- Epidural
|
|
Circulatory system |
|
|
Musculoskeletal system |
- Intramuscular
- Intraosseous
|
|
Skin |
- Epicutaneous
- Intradermal
- Subcutaneous
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
- Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leòn FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD.SourceInstitute for Health Metrics and Evaluation, Seattle 98121, WA, USA. cjlm@uw.edu
- Lancet.Lancet.2013 Dec 15;380(9859):2197-223. doi: 10.1016/S0140-6736(12)61689-4.
- BACKGROUND: Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. The 1990 Global Burden of Disease study proposed disability-adjusted life years (DALYs) to measure disease burden. No compr
- PMID 23245608
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
- Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Ma J, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leòn FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, Murray CJ.SourceSchool of Population Health, Brisbane, QLD, Australia.
- Lancet.Lancet.2013 Dec 15;380(9859):2163-96. doi: 10.1016/S0140-6736(12)61729-2.
- BACKGROUND: Non-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the only studies to quantify non-fatal health outcomes across a
- PMID 23245607
- Effects of dose and route of administration of genistein on isoflavone concentrations in post-weaned and gestating sows.
- Farmer C, Robertson P, Gilani GS.Source1 Agriculture and Agri-Food Canada, Dairy and Swine Research and Development Centre, 2000 College Street, Sherbrooke, QC J1M 0C8 Canada.
- Animal : an international journal of animal bioscience.Animal.2013 Feb 1:1-7. [Epub ahead of print]
- Phytoestrogens could be a useful tool in swine husbandry practices because of their structural and functional similarities to estradiol. The goal of this study was to compare various routes and doses of administration of the phytoestrogen genistein in sows of two different physiological statuses. Ci
- PMID 23369600
Japanese Journal
- In Vivo Anti-diabetic and Anti-oxidant Potential of Psoralea corylifolia Seeds in Streptozotocin Induced Type-2 Diabetic Rats
- Kamboj Jitpal,Sharma Sunil,Kumar Suresh
- JOURNAL OF HEALTH SCIENCE 57(3), 225-235, 2011
- … After 28 days (chronic study) of treatment with extract the maximum reduction in blood glucose level were observed in streptozotocin-nicotinamide rats with ethanolic extract 400 mg/kg body weight per os. …
- NAID 130000800083
- Medicinal Flowers. XXXII. : Structures of Oleanane-Type Triterpene Saponins, Perennisosides VIII, IX, X, XI, and XII, from the Flowers of Bellis perennis
- Morikawa Toshio,Li Xuezheng,Nishida Eriko,Nakamura Seikou,Ninomiya Kiyofumi,Matsuda Hisashi,Hamao Makoto,Muraoka Osamu,Hayakawa Takao,Yoshikawa Masayuki
- CHEMICAL & PHARMACEUTICAL BULLETIN 59(7), 889-895, 2011
- … perennis was found to inhibit gastric emptying in olive oil-loaded mice at a dose of 200 mg/kg, per os (p.o.). …
- NAID 130000748026
Related Links
- 2 days ago ... A wide range of fairtrade and ethcial products for the foodservice industry.
Related Pictures
★リンクテーブル★
[★]
⇔parenteral
- 関
- orally、p.o.、per os、peroral、perorally
[★]
- 関
- oral、per os、peroral、perorally
[★]
- 関
- oral、orally、p.o.、per os、perorally
[★]
- 英
- oral、peroral、orally、perorally、per os
- 関
- 経口、口頭
[★]
- 英
- oral、peroral、per os、p.o.
- 関
- 経口的、口頭
[★]
皮膚骨膜肥厚症、肥大性皮膚骨膜症、厚皮骨膜症、強皮骨膜症
[★]
- 関
- proper vibration
[★]
- cent os/redhat version check -> # cat /etc/redhat-release
[★]
- (商)~につき/ごとに
- ~で、~によって。~に託して
- ~によれば
[★]
- 関
- protein efficiency ratio
[★]
骨
- 関
- bone、osseous、osteo
[★]